US 8124617
Imidazopyridine compounds
granted A61KA61K31/437A61K9/2018
Quick answer
US patent 8124617 (Imidazopyridine compounds) held by Takeda Pharmaceutical Company Limited expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/437, A61K9/2018, A61K9/4858, A61P